Display options
Cite
Kristiansen IS, Kvien TK. Cost-effectiveness of replacing NSAIDs with coxibs: diclofenac and celecoxib in rheumatoid arthritis. Expert Rev Pharmacoecon Outcomes Res. 2002;2(3):229-41doi: 10.1586/14737167.2.3.229.
Kristiansen, I. S., & Kvien, T. K. (2002). Cost-effectiveness of replacing NSAIDs with coxibs: diclofenac and celecoxib in rheumatoid arthritis. Expert review of pharmacoeconomics & outcomes research, 2(3), 229-41. https://doi.org/10.1586/14737167.2.3.229
Kristiansen, Ivar Sønbø, and Kvien, Tore Kristian. "Cost-effectiveness of replacing NSAIDs with coxibs: diclofenac and celecoxib in rheumatoid arthritis." Expert review of pharmacoeconomics & outcomes research vol. 2,3 (2002): 229-41. doi: https://doi.org/10.1586/14737167.2.3.229
Kristiansen IS, Kvien TK. Cost-effectiveness of replacing NSAIDs with coxibs: diclofenac and celecoxib in rheumatoid arthritis. Expert Rev Pharmacoecon Outcomes Res. 2002 Jun;2(3):229-41. doi: 10.1586/14737167.2.3.229. PMID: 19807415.
Copy Download .nbib Format: NLM
Share it on

Expert Rev Pharmacoecon Outcomes Res. 2002 Jun;2(3):229-41. doi: 10.1586/14737167.2.3.229.

Cost-effectiveness of replacing NSAIDs with coxibs: diclofenac and celecoxib in rheumatoid arthritis.

Expert review of pharmacoeconomics & outcomes research

Ivar Sønbø Kristiansen, Tore Kristian Kvien

Affiliations

  1. Institute of Public Health - Health Economics Research Unit, University of Southern Denmark, Odense, 19 Winsløw Park, DK-5000 Odense C, Denmark. [email protected]

PMID: 19807415 DOI: 10.1586/14737167.2.3.229

Abstract

Cyclooxygenase-2 inhibitors exhibit the same effectiveness on rheumatic symptoms as nonsteroidal anti-inflammatory drugs, have fewer gastrointestinal side effects, but a higher price. Based on cost and healthcare utilization in Norway, this paper explores what factors are most important for the cost-effectiveness of cyclooxygenase-2 inhibitors and points to patient groups that may be most relevant for prescribing coxibs instead of nonsteroidal anti-inflammatory drugs.

Publication Types